• Frontier Medicines raises $88M for R&D, including potential rival to Amgen cancer drug

    3 monthes ago - By MedCity News

    Cancer drug developer Frontier Medicines already has a research partnership with AbbVie. Now the preclinical-stage biotech has raised $88.5 million for its own pipeline, including a drug that could offer advantages over a recently approved Amgen cancer therapy.
    Read more ...